Potential Utility of Liquid Biopsy as a Diagnostic and Prognostic Tool for the Assessment of Solid Tumors: Implications in the Precision Oncology
- PMID: 30889786
- PMCID: PMC6463095
- DOI: 10.3390/jcm8030373
Potential Utility of Liquid Biopsy as a Diagnostic and Prognostic Tool for the Assessment of Solid Tumors: Implications in the Precision Oncology
Abstract
Liquid biopsy is a technique that utilizes circulating biomarkers in the body fluids of cancer patients to provide information regarding the genetic landscape of the cancer. It is emerging as an alternative and complementary diagnostic and prognostic tool to surgical biopsy in oncology. Liquid biopsy focuses on the detection and isolation of circulating tumor cells, circulating tumor DNA and exosomes, as a source of genomic and proteomic information in cancer patients. Liquid biopsy is expected to provide the necessary acceleratory force for the implementation of precision oncology in clinical settings by contributing an enhanced understanding of tumor heterogeneity and permitting the dynamic monitoring of treatment responses and genomic variations. However, widespread implementation of liquid biopsy based biomarker-driven therapy in the clinical practice is still in its infancy. Technological advancements have resolved many of the hurdles faced in the liquid biopsy methodologies but sufficient clinical and technical validation for specificity and sensitivity has not yet been attained for routine clinical implementation. This article provides a comprehensive review of the clinical utility of liquid biopsy and its effectiveness as an important diagnostic and prognostic tool in colorectal, breast, hepatocellular, gastric and lung carcinomas which were the five leading cancer related mortalities in 2018.
Keywords: cancer diagnosis; cancer prognosis; circulating tumor DNA (ctDNA); circulating tumor cells (CTCs); exosomes; liquid biopsy.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology.Ther Adv Med Oncol. 2018 Aug 29;10:1758835918794630. doi: 10.1177/1758835918794630. eCollection 2018. Ther Adv Med Oncol. 2018. PMID: 30181785 Free PMC article. Review.
-
The latest advances in liquid biopsy for lung cancer-a narrative review.Transl Lung Cancer Res. 2024 Nov 30;13(11):3241-3251. doi: 10.21037/tlcr-24-828. Epub 2024 Nov 27. Transl Lung Cancer Res. 2024. PMID: 39669995 Free PMC article. Review.
-
Liquid Biopsy in Clinical Management of Breast, Lung, and Colorectal Cancer.Front Med (Lausanne). 2018 Jan 30;5:9. doi: 10.3389/fmed.2018.00009. eCollection 2018. Front Med (Lausanne). 2018. PMID: 29441349 Free PMC article. Review.
-
Liquid biopsy: will it be the 'magic tool' for monitoring response of solid tumors to anticancer therapies?Curr Opin Oncol. 2015 Nov;27(6):560-7. doi: 10.1097/CCO.0000000000000223. Curr Opin Oncol. 2015. PMID: 26335664 Review.
-
Liquid biopsy in breast cancer: A comprehensive review.Clin Genet. 2019 Jun;95(6):643-660. doi: 10.1111/cge.13514. Epub 2019 Feb 27. Clin Genet. 2019. PMID: 30671931 Review.
Cited by
-
Urinary extracellular vesicles: a rising star in bladder cancer management.Transl Androl Urol. 2021 Apr;10(4):1878-1889. doi: 10.21037/tau-20-1039. Transl Androl Urol. 2021. PMID: 33968676 Free PMC article. Review.
-
Matrix Vesicles: Role in Bone Mineralization and Potential Use as Therapeutics.Pharmaceuticals (Basel). 2021 Mar 24;14(4):289. doi: 10.3390/ph14040289. Pharmaceuticals (Basel). 2021. PMID: 33805145 Free PMC article. Review.
-
A Two-Dimensional Affinity Capture and Separation Mini-Platform for the Isolation, Enrichment, and Quantification of Biomarkers and Its Potential Use for Liquid Biopsy.Biomedicines. 2020 Jul 30;8(8):255. doi: 10.3390/biomedicines8080255. Biomedicines. 2020. PMID: 32751506 Free PMC article. Review.
-
Subpopulations of Circulating Cells with Morphological Features of Malignancy Are Preoperatively Detected and Have Differential Prognostic Significance in Non-Small Cell Lung Cancer.Cancers (Basel). 2021 Sep 6;13(17):4488. doi: 10.3390/cancers13174488. Cancers (Basel). 2021. PMID: 34503298 Free PMC article.
-
Liquid Biopsies in a Veteran Patient Population With Advanced Prostate and Lung Non-Small Cell Carcinomas: A New Paradigm and Unique Challenge in Personalized Medicine.Fed Pract. 2021 Jan;38(1):8-14. doi: 10.12788/fp.0065. Fed Pract. 2021. PMID: 33574643 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources